Episode 1088: All My Antibiotics: The CAP Guideline Drama

Episode 1088: All My Antibiotics: The CAP Guideline Drama

In this episode, I’ll discuss the recent conflict between ATS and IDSA over the Community Acquired Pneumonia guidelines. New guidelines for treating patients with community-acquired pneumonia were published earlier in 2025 by the American Thoracic Society, but unlike previous versions, these were not endorsed by the Infectious Disease Society of America. The reason for IDSA’s…

Read More
EMCrit 1:1 Nursing 007 – Resus Nurse Efficiency

EMCrit 1:1 Nursing 007 – Resus Nurse Efficiency

In this episode, Scott sits down with Candice to unpack how experienced emergency resus nurses manage overwhelming workloads in real-world conditions. Candice walks us through how she prioritizes care, uses geography and technology to maintain situational awareness, and builds redundancy through teamwork. The conversation covers practical strategies for time management, monitoring, charting, nurse autonomy, and…

Read More
Diagnosis and management of osteomyelitis – PEMBlog

Diagnosis and management of osteomyelitis – PEMBlog

Pediatric osteomyelitis is common enough to be missed and serious enough that missing it matters. Over the last decade, however, how we diagnose and treat acute hematogenous osteomyelitis (AHO) in children has changed substantially. Prolonged intravenous antibiotics, fixed treatment durations, and reflexive surgery are no longer the default for uncomplicated disease. What follows is a…

Read More
Is Abelacimab the Next Step in AF Anticoagulation? Early Signals and Remaining Questions – REBEL EM

Is Abelacimab the Next Step in AF Anticoagulation? Early Signals and Remaining Questions – REBEL EM

This Phase 2 trial exhibited an atypical primary focus on safety outcomes, specifically bleeding risks. While Phase 2 trials commonly assess a drug’s efficacy in treating the targeted condition (e.g., stroke prevention), this study did not align with that norm (however, did in part examine dose-dependent differences). Ultimately, clinicians will require an understanding of this…

Read More
Episode 1087: Make sure newbie hospital pharmacists (and students) know this about vancomycin by multiple routes of administration

Episode 1087: Make sure newbie hospital pharmacists (and students) know this about vancomycin by multiple routes of administration

In this episode, I’ll discuss whether it is ever appropriate for a patient to be on vancomycin by more than one route of administration. While IV vancomycin is indicated for a variety of infectious diseases, oral vancomycin is primarily used to treat Clostridioides difficile infection (CDI). Unlike IV metronidazole, which achieves therapeutic levels in the…

Read More
Influenza A and B in Children: Same Illness, Different Letter?

Influenza A and B in Children: Same Illness, Different Letter?

Influenza A and B infections in children are clinically similar in presentation and severity, with no consistent differences in symptoms, disease duration, or outcomes, though some studies suggest subtle variations in specific manifestations and age distribution. Clinical Presentation The clinical presentations of influenza A and B are largely indistinguishable. Both types cause acute onset of…

Read More